Biallelic mutations in DYNC2LI1 are a rare cause of Ellis-van Creveld syndrome

M Niceta, K Margiotti, M C Digilio, V Guida, A Bruselles, S Pizzi, A Ferraris, L Memo, N Laforgia, M L Dentici, F Consoli, I Torrente, V L Ruiz-Perez, B Dallapiccola, B Marino, A De Luca, M Tartaglia

Research output: Contribution to journalArticle

Abstract

Ellis-van Creveld syndrome (EvC) is a chondral and ectodermal dysplasia caused by biallelic mutations in the EVC, EVC2 and WDR35 genes. A proportion of cases with clinical diagnosis of EvC, however, do not carry mutations in these genes. To identify the genetic cause of EvC in a cohort of mutation-negative patients, exome sequencing was undertaken in a family with 3 affected members, and mutation scanning of a panel of clinically and functionally relevant genes was performed in 24 additional subjects with features fitting/overlapping EvC. Compound heterozygosity for the c.2T>C (p.Met1?) and c.662C>T (p.Thr221Ile) variants in DYNC2LI1, which encodes a component of the intraflagellar transport-related dynein-2 complex previously found mutated in other short-rib thoracic dysplasias, was identified in the 3 affected members of the first family. Targeted resequencing detected compound heterozygosity for the same missense variant and a truncating change (p.Val141*) in 2 siblings with EvC from a second family, while a newborn with a more severe phenotype carried 2 DYNC2LI1 truncating variants. Our findings indicate that DYNC2LI1 mutations are associated with a wider clinical spectrum than previously appreciated, including EvC, with the severity of the phenotype likely depending on the extent of defective DYNC2LI1 function.

Original languageEnglish
JournalClinical Genetics
DOIs
Publication statusE-pub ahead of print - Aug 30 2017

Fingerprint

Ellis-Van Creveld Syndrome
Mutation
Genes
Exome
Ectodermal Dysplasia
Phenotype
Dyneins
Ribs
Cartilage
Siblings
Thorax
Newborn Infant

Keywords

  • Journal Article

Cite this

Biallelic mutations in DYNC2LI1 are a rare cause of Ellis-van Creveld syndrome. / Niceta, M; Margiotti, K; Digilio, M C; Guida, V; Bruselles, A; Pizzi, S; Ferraris, A; Memo, L; Laforgia, N; Dentici, M L; Consoli, F; Torrente, I; Ruiz-Perez, V L; Dallapiccola, B; Marino, B; De Luca, A; Tartaglia, M.

In: Clinical Genetics, 30.08.2017.

Research output: Contribution to journalArticle

@article{c15256c4183c46f19d013107bc19a520,
title = "Biallelic mutations in DYNC2LI1 are a rare cause of Ellis-van Creveld syndrome",
abstract = "Ellis-van Creveld syndrome (EvC) is a chondral and ectodermal dysplasia caused by biallelic mutations in the EVC, EVC2 and WDR35 genes. A proportion of cases with clinical diagnosis of EvC, however, do not carry mutations in these genes. To identify the genetic cause of EvC in a cohort of mutation-negative patients, exome sequencing was undertaken in a family with 3 affected members, and mutation scanning of a panel of clinically and functionally relevant genes was performed in 24 additional subjects with features fitting/overlapping EvC. Compound heterozygosity for the c.2T>C (p.Met1?) and c.662C>T (p.Thr221Ile) variants in DYNC2LI1, which encodes a component of the intraflagellar transport-related dynein-2 complex previously found mutated in other short-rib thoracic dysplasias, was identified in the 3 affected members of the first family. Targeted resequencing detected compound heterozygosity for the same missense variant and a truncating change (p.Val141*) in 2 siblings with EvC from a second family, while a newborn with a more severe phenotype carried 2 DYNC2LI1 truncating variants. Our findings indicate that DYNC2LI1 mutations are associated with a wider clinical spectrum than previously appreciated, including EvC, with the severity of the phenotype likely depending on the extent of defective DYNC2LI1 function.",
keywords = "Journal Article",
author = "M Niceta and K Margiotti and Digilio, {M C} and V Guida and A Bruselles and S Pizzi and A Ferraris and L Memo and N Laforgia and Dentici, {M L} and F Consoli and I Torrente and Ruiz-Perez, {V L} and B Dallapiccola and B Marino and {De Luca}, A and M Tartaglia",
note = "{\circledC} 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",
year = "2017",
month = "8",
day = "30",
doi = "10.1111/cge.13128",
language = "English",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Biallelic mutations in DYNC2LI1 are a rare cause of Ellis-van Creveld syndrome

AU - Niceta, M

AU - Margiotti, K

AU - Digilio, M C

AU - Guida, V

AU - Bruselles, A

AU - Pizzi, S

AU - Ferraris, A

AU - Memo, L

AU - Laforgia, N

AU - Dentici, M L

AU - Consoli, F

AU - Torrente, I

AU - Ruiz-Perez, V L

AU - Dallapiccola, B

AU - Marino, B

AU - De Luca, A

AU - Tartaglia, M

N1 - © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PY - 2017/8/30

Y1 - 2017/8/30

N2 - Ellis-van Creveld syndrome (EvC) is a chondral and ectodermal dysplasia caused by biallelic mutations in the EVC, EVC2 and WDR35 genes. A proportion of cases with clinical diagnosis of EvC, however, do not carry mutations in these genes. To identify the genetic cause of EvC in a cohort of mutation-negative patients, exome sequencing was undertaken in a family with 3 affected members, and mutation scanning of a panel of clinically and functionally relevant genes was performed in 24 additional subjects with features fitting/overlapping EvC. Compound heterozygosity for the c.2T>C (p.Met1?) and c.662C>T (p.Thr221Ile) variants in DYNC2LI1, which encodes a component of the intraflagellar transport-related dynein-2 complex previously found mutated in other short-rib thoracic dysplasias, was identified in the 3 affected members of the first family. Targeted resequencing detected compound heterozygosity for the same missense variant and a truncating change (p.Val141*) in 2 siblings with EvC from a second family, while a newborn with a more severe phenotype carried 2 DYNC2LI1 truncating variants. Our findings indicate that DYNC2LI1 mutations are associated with a wider clinical spectrum than previously appreciated, including EvC, with the severity of the phenotype likely depending on the extent of defective DYNC2LI1 function.

AB - Ellis-van Creveld syndrome (EvC) is a chondral and ectodermal dysplasia caused by biallelic mutations in the EVC, EVC2 and WDR35 genes. A proportion of cases with clinical diagnosis of EvC, however, do not carry mutations in these genes. To identify the genetic cause of EvC in a cohort of mutation-negative patients, exome sequencing was undertaken in a family with 3 affected members, and mutation scanning of a panel of clinically and functionally relevant genes was performed in 24 additional subjects with features fitting/overlapping EvC. Compound heterozygosity for the c.2T>C (p.Met1?) and c.662C>T (p.Thr221Ile) variants in DYNC2LI1, which encodes a component of the intraflagellar transport-related dynein-2 complex previously found mutated in other short-rib thoracic dysplasias, was identified in the 3 affected members of the first family. Targeted resequencing detected compound heterozygosity for the same missense variant and a truncating change (p.Val141*) in 2 siblings with EvC from a second family, while a newborn with a more severe phenotype carried 2 DYNC2LI1 truncating variants. Our findings indicate that DYNC2LI1 mutations are associated with a wider clinical spectrum than previously appreciated, including EvC, with the severity of the phenotype likely depending on the extent of defective DYNC2LI1 function.

KW - Journal Article

U2 - 10.1111/cge.13128

DO - 10.1111/cge.13128

M3 - Article

C2 - 28857138

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

ER -